Literature DB >> 31188240

Metabolic Syndrome Reversal With Cariprazine.

Angelos Halaris1, Jessica Wuest.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31188240     DOI: 10.1097/JCP.0000000000001074

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN: 0271-0749            Impact factor:   3.153


× No keyword cloud information.
  4 in total

Review 1.  Treating schizophrenia with cariprazine: from clinical research to clinical practice. Real world experiences and recommendations from an International Panel.

Authors:  Andrea Fagiolini; José Ángel Alcalá; Thomas Aubel; Wojciech Bienkiewicz; Mats Magnus Knut Bogren; Joaquim Gago; Giancarlo Cerveri; Michael Colla; Francisco Collazos Sanchez; Alessandro Cuomo; Frieling Helge; Eduardo Iacoponi; Per-Axel Karlsson; Pradeep Peddu; Mauro Pettorruso; Henrique Jorge Ramos Pereira; Johan Sahlsten Schölin; Ingo Bernd Vernaleken
Journal:  Ann Gen Psychiatry       Date:  2020-09-26       Impact factor: 3.455

2.  Cariprazine's Potential in Improving Social Dysfunction in Patients With Schizophrenia: A Perspective.

Authors:  Petr Morozov; Roman Bekker; Youri Bykov
Journal:  Front Psychiatry       Date:  2022-04-27       Impact factor: 5.435

3.  The More, the Merrier…? Antipsychotic Polypharmacy Treatment Strategies in Schizophrenia From a Pharmacology Perspective.

Authors:  Stephan Hjorth
Journal:  Front Psychiatry       Date:  2021-11-24       Impact factor: 4.157

4.  Real-Life Clinical Experience With Cariprazine: A Systematic Review of Case Studies.

Authors:  Réka Csehi; Zsófia Borbála Dombi; Barbara Sebe; Mária Judit Molnár
Journal:  Front Psychiatry       Date:  2022-03-17       Impact factor: 4.157

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.